Historical Stock Price
DFFN historical stock prices picture
DFFN (DFFN) has the following price history information. Looking back at DFFN historical stock prices for the last five trading days, on August 11, 2023, DFFN opened at $3.45, traded as high as $3.57 and as low as $3.45, and closed at $3.47. Trading volume was a total of 10.50K shares. On August 14, 2023, DFFN opened at $3.45, traded as high as $3.65 and as low as $3.45, and closed at $3.65. Trading volume was a total of 30.70K shares. On August 15, 2023, DFFN opened at $3.62, traded as high as $4.07 and as low as $3.56, and closed at $3.94. Trading volume was a total of 85.90K shares. On August 16, 2023, DFFN opened at $4.23, traded as high as $5.19 and as low as $4.17, and closed at $4.40. Trading volume was a total of 349.50K shares. On August 17, 2023, DFFN opened at $3.00, traded as high as $3.00 and as low as $3.00, and closed at $3.00. Trading volume was a total of 0 shares.

DFFN Historical Stock Prices By Date:

DFFN historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into DFFN shares, starting with a $10,000 purchase of DFFN, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/31/2014
End date: 08/17/2023
Start price/share: $67,500.00
End price/share: $3.00
Dividends collected/share: $0.00
Total return: -100.00%
Average Annual Total Return: -65.62%
Starting investment: $10,000.00
Ending investment: $0.44
Years: 9.39
Date Open High Low Close Volume
08/11/2023 $3.45 $3.57 $3.45 $3.47 10.50K
08/14/2023 $3.45 $3.65 $3.45 $3.65 30.70K
08/15/2023 $3.62 $4.07 $3.56 $3.94 85.90K
08/16/2023 $4.23 $5.19 $4.17 $4.40 349.50K
08/17/2023 $3.00 $3.00 $3.00 $3.00 0
Diffusion Pharmaceuticals is a clinical stage biotechnology company. Co. is developing its primary product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC). TSC is designed to selectively target and re-oxygenate the micro-environment of hypoxic cells, and can potentially be used in various indications, including stroke, oncology and cardiovascular disease. Co.'s oncology program targets TSC against treatment-resistant brain cancer. In addition to the TSC programs, Co. is exploring alternatives to capitalize upon its product candidate RES-529, a PI3K/Akt/mTOR pathway inhibitor for age-related macular degeneration.
Date Close
08/11/2023$3.47
08/14/2023$3.65
08/15/2023$3.94
08/16/2023$4.40
08/17/2023$3.00
DFFN is categorized under the Healthcare sector; below are some other companies in the same sector:

DGX Historical Stock Prices
DHR Historical Stock Prices
DHRM Historical Stock Prices
DMA Historical Stock Prices
DMPI Historical Stock Prices
DMTX Historical Stock Prices
DNAI Historical Stock Prices
DND Historical Stock Prices
DNDN Historical Stock Prices
DOVA Historical Stock Prices

Also explore: DFFN shares outstanding history

Email EnvelopeFree DFFN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


DFFN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.